ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintSite TitleTitle ChevronIcon Twitter
Science

Kyoto University, German drugmaker to research hearing loss treatment

TOKYO -- A German pharmaceutical firm will work with Kyoto University to develop a treatment for hearing loss, aiming to build on the institution's research to find a way to regenerate important cells in the inner ear.

     Boehringer Ingelheim is the only major foreign pharmaceutical company to maintain drug development facilities in Japan. The company has little experience with hearing disorders, instead concentrating on such areas as circulatory and respiratory diseases. Its move into the field is part of a strategy of focusing on ailments with no treatment options.

     Takayuki Nakagawa, a senior lecturer at Kyoto University and a member of its Inner Ear Research Group, will work with about 10 scientists from Boehringer. The team will research ways to regenerate hair cells in the inner ear, which convert sound waves into electrical signals and send them to the brain.

     The partnership will begin in April and last three years. The research will likely cost tens of millions of yen (10 million yen equals $88,950) a year. This is an unusual move for Kyoto University, which rarely works with foreign pharmaceutical companies from the initial stage of drug development.

      Sensorineural hearing loss, one of the most common disabilities, is caused by damage to hair cells or nerves in the inner ear. Although curing this condition completely is regarded as difficult, a number of research breakthroughs opening up potential treatment avenues have been announced recently.

(Nikkei)

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Get Unlimited access

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends April 30th

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media